Participants
Study participants were part of a larger HPV self-sampling randomized clinical trial, the Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) study (As part of the trial, we conducted a nested survey to assess acceptability and experiences among a subset of randomly selected trial participants randomized to home-based self-sampling for HPV testing. This study includes telephone survey participants who responded between August 2020 and September 2022. Telephone survey participants were a random sample of women selected from each of four categories based on two factors: receipt of patient navigation (yes [Arm 3] or no [Arm 2]) and kit completed and returned within 6 months of randomization (yes or no). Women who require clinical follow-up were not eligible for this survey.